Minerva Neurosciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.55

+0.12 (+2.21%)

As of Jun 30, 10:24 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 6 67%

Hold 3 33%

Sell 0 0%

Price Target

Analyst Price Target -27.4% upside

Low Target $3.03

Average Target $4.03

High Target $5.66

Current Price $5.55

Current
$5.55

Target
$4.03

$3.03 $4.03 avg $5.66

Scenario Analysis

Bear Case

$3.03

-45.4%

Low target

Base Case

$4.03

-27.4%

Avg target

Bull Case

$5.66

+2.0%

High target

Risk/Reward

0.0x

Unfavorable

Price in Context

52-Week High

$12.46

-55.5% from high

52-Week Low

$1.57

+254.4% from low

Target vs 52W High

$4.03

-67.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%